occurs in about 75% of all women during reproductive age, and around half of those will have at least one recurrent episode. Objectives: To evaluate the occurrence of Candida species in the genital tract of women attending a clinic of Gynecology and Obstetrics at the University Hospital for gynecological interventions, related to signs and symptoms of infection and also to evaluate the susceptibility to antifungal agents of the Candida isolates. Methods and materials: Samples of vaginal secretions were taken of 128 women during gynecological and colposcopic examination, through sterile swab, to carry out culture for fungi. Susceptibility tests were performed for fluconazole, itraconazole, voriconazole, nystatin and amphotericin B. Results: Twenty (15.6%) patients had positive culture for yeasts identified as: C. albicans (57.1%), C. glabrata (19%), C. parapsilosis complex (4.8%), C. lipolytica (4.8%), Trichosporon sp (9.5%), and Rhodotorula sp (4.8%). Ninety women (70.3%) reported no symptoms and 38 (29.6%) were symptomatic. The most frequent complaints were: discharge, vulval itching, and dyspareunia. All isolates were susceptible to the antifungal agents tested, except for some isolates of C. parapsilosis complex, which showed in vitro resistance to itraconazole. Conclusions: Although Candida species were isolated in only some of the women, C. albicans was the most common species. The more frequent complaints were discharge and vulvar itching. Most of the isolates were susceptible to the antifungals tested.
Diseases that affect the vulva and vagina can have different causes. Infectious vaginitis is mainly caused by bacteria, yeasts and Trichomonas vaginalis 1, 2 . Among these diseases, vulvovaginal candidiasis (VVC) is the second most common infection, representing 20 to 30% of gynecologic diseases occurring in women aged 20 to 30 years 3 . VVC occurs in about 75% of all women during reproductive age, and around half of those will have at least one recurrent episode. It is seen more frequently in women in sexual activity, possibly due to colonizing microorganisms penetrating the epithelium 4 .
Candida genus comprises several species, of which only a few are able to cause human infections, and the species responsible for vulvovaginitis are mainly C. albicans, but also others like C. glabrata, C. tropicalis, C. krusei and C. parapsilosis
Clinically, VVC is characterized by the occurrence of intense vulvar itching, vaginal discharge, dyspareunia, dysuria, edema and vulvovaginal erythema, as well as signs of inflammation accompanied by burning when urinating. The misdiagnosis of infectious agent may lead to incorrect treatment, resulting in permanent symptoms or a recurrence of infection 5, 6 .
Multiple factors contribute to the onset and development of VVC: genetic, hormonal, advanced age, diseases such as diabetes, stress, poor local hygiene, sharing underwear, tight clothing, use of antibiotics and factors related to the state of immunosuppression of the individual 7 . The transmission of infectious agents can occur through contact with mucous membranes and skin secretions of patients with Candida spp., or sickness, sexual contact, contaminated water and vertical transmission during childbirth 2, 8 .
The diagnosis of VVC is performed clinically, associating history with pelvic examination and the assistance of laboratory analysis of clinical specimens. Laboratory tests may be use secretions which are immediately analyzed microscopically. Fungal culture mainly contributes to determine the species causing vulvovaginitis and is the gold standard 
METHODS
This is an exploratory and quantitative study carried out at the clinic of Gynecology and Obstetrics at the Clinical Hospital of the Federal University of Uberlandia, Minas Gerais, Brazil. The sample included 128 non-pregnant women aged 18 years or more, who were sent to the service for gynecological interventions (hysterectomy or perineoplasty with sling) in the period from July to November 2013.
All study subjects agreed to participate and signed the free and informed consent form. The approach to the patients included interview and collection of vaginal secretion specimens to conduct culture for fungi, and after susceptibility testing to antifungal drugs. The study was approved by the Ethics Committee on Human Research of the Federal University of Uberlandia (number 307.615/2013, CAAE 14189513.5.0000.5152).
The collection of clinical specimens for research into fungal structures was done after gynecologic inspection. A sterilized swab with a long stem was used, which was introduced directly into the vaginal canal, in the vaginal fornix and endocervical region, gently rolled and placed in Stuart transport medium for further processing in the laboratory.
The samples contained in the swabs were plated sequentially on Petri dishes (90x15 mm) containing Sabouraud dextrose agar added by chloramphenicol, and in another dish containing chromogenic agar for In women undergoing gynecologic intervention procedures, such as hysterectomy or perineoplasty, there are few studies that refer to infection or fungal colonization before or after those procedures. Then, this study aimed to evaluate the occurrence of Candida species in the genital tract of women attending a clinic of Gynecology and Obstetrics at the University Hospital for gynecological interventions, in order to relate signs and symptoms of infection and assess the susceptibility of the isolates to antifungal agents.
Candida (Pronadisa, Madrid, Spain). The plates were incubated at 30°C for up to 5 days, and growth of colonies was monitored daily. The green colored colonies on chromogenic agar for Candida were identified presumptively as C. albicans. Other species were identified using the classical methodology: germ tube, micromorphological analysis cornmeal agarTween 80, and auxanogram 11 . If there was need, the identification was also made in Auxacolor™ commercial kit (Bio-Rad, Rio de Janeiro, RJ, Brazil) and/or FungiFast®. C. albicans and C. dubliniensis were differentiated by PCR utilizing specific primers, according to Estrada-Barraza et al.
12
.
The susceptibility testing to antifungal agents was made by disk diffusion method in agar, according to the M44-A2 document of the Clinical Laboratory Standards Institute 13 . The disks used contained the following antifungals: fluconazole (25 µg, Cecon, São Paulo, SP, Brazil), itraconazole (10 µg, Cecon, São Paulo, SP, Brazil), voriconazole (1 µg, Bio-Rad, Marnes-la-Coquette, France), nystatin (100 U, BioRad, Marnes-la-Coquette, France) and amphotericin B (1 µg Bio-Rad, Marnes-la-Coquette, France). The cutoff points for the halos were those indicated by the CLSI for fluconazole 13 , and when not available, the cutoffs listed in the manufacturer's instructions were used. The standard strains C. parapsilosis ATCC 22019 and C. albicans ATCC 90028 were used as controls.
Data were related in absolute and relative frequency distribution tables. The G and Fisher's exact test were used for the association between the colonization variables and predisposing factors for the development of vulvovaginal candidiasis. The statistical significance was defined at 95% (P ≤0.05).
RESULTS
The women's ages ranged from 18 to 83 years, with an average and median of 48 and 46 years, respectively. Clinical specimens of twenty women (15.6%) showed positive culture. The isolates are shown in Table 1 Ninety (70.3%) women reported being asymptomatic and 38 (29.6%) had non-specific symptoms, which were compatible with VVC. The main complaints were discharge, vulval itching, dyspareunia, external dysuria and vaginal burning ( Table 2 ). In relation to symptoms reported by patients with positive culture, nine had one or more signs and symptoms: seven reported discharge, two had vaginal burning, six had vulvar itching, six had dyspareunia and three had external dysuria. Candida species related to these symptoms were C. albicans (six women), C. albicans associated with Trichosporon sp (one woman), C. glabrata (one) and C. lipolytica (one). Table 2 also shows that the discharge occurrences and dyspareunia were associated with the culture results (P ≤0.05). Six women with a positive culture (30%) reported having simultaneously vaginal discharge, vulvar itching and dyspareunia.
All isolates of
The socio-demographic profile of the sample of the study population is shown in Table 3 . Most women lived in urban areas (96.8%) and were 40 years of age or older. Caucasian women who self-reported corresponded to 67.9% of the total, while black women accounted for 19.5%. Of the participants who had a positive culture for fungi, 80% reported having an active sex life. 
DISCUSSION
Infections of the reproductive tract, including sexually transmitted infections, deserve special attention of public health 14 . Vulvovaginal candidiasis affects millions of women of all ages each year, causing great discomfort, negatively impacting sexual and emotional relationships 6, 14 .
In present study, 20 (15.6%) women had a positive vaginal culture for yeast. Compared to the literature, it is observed that this frequency is considerably lower than those reported in other studies (usually at a frequency greater than 30%) 9, 15, 16 . This was probably because the sample population included in this study was of women attending the outpatient clinic of General Gynecology, which were forwarded by Health Services of the municipality, after screening by the primary care network gynecologist, requiring gynecological interventions (hysterectomy, perineoplasty with sling). Thus, it becomes important for this study to highlight the need for research and subsequent treatment of the infection, before any intervention of another kind, such as surgical.
Candida species were isolated in 90% (18/20) of samples which were positive for yeast. Some studies conducted in Brazil reported the incidence of C. albicans ranging from 53.2% to 81.25% of all the isolates, followed by C. glabrata 2, 15, 16 . Uncommon species such as Rhodotorula sp and Trichosporon sp can be found associated with other species or genera, including Candida. Among Candida species, C. lipolytica was isolated in one patient; however, there is no confirmation in the literature about the pathogenicity of this species. Mardh et al. 5 showed that the incidence is variable for different species, and that Candida-non-C. albicans species contribute to the high resistance to treatment. In addition, recent studies have showed that new species C. glabrata related, C. nivariensis and C. bracarensis, exist in the vaginal samples of patients with VVC 17 .
The complaints reported by women were vaginal discharge, vulval itching, dyspareunia, external dysuria, and vaginal burning, and were mainly referred by women who had positive culture for fungi. Regarding the symptoms, discharge and dyspareunia were statistically significant. Vaginal discharge was the most frequently reported by patients (see Table 2 ). This sign is one of the most common concerns among women, especially those of reproductive age 18 .
It is noteworthy that the clinical symptoms of VVC are non-specific and can be associated with a variety of other diseases and vaginal infections such as bacterial vaginosis, trichomoniasis, gonorrhea and chlamydia. It is also noted that many genital infections are asymptomatic; therefore, laboratory tests are important in the diagnosis and identification of the causative organism 1, 19 . Some species, such as C. glabrata and C. krusei may not respond to treatment when fluconazole is chosen as the antifungal. C. glabrata can develop resistance during treatment, and C. krusei is intrinsically resistant to this antifungal 20 .
It is also worth mentioning that sexual partners may be important reservoirs of Candida species and be related to the maintenance of vulvovaginal candidiasis 19 . However, sexual partners of women with VVC do not need to be treated unless they have symptoms 14 .
Preventing VVC can be achieved with the right treatment, followed by changes to behavior and habits. The health education actions for guidance include proper genital hygiene, use of appropriate clothing for the weather, vaginal douches, use of intimate deodorants and soaps, and even safe sex practices, all of which enable the prevention or the exacerbation of symptoms 7 .
With this study, we concluded that the occurrence of VVC in the population is lower than that reported in the literature and C. albicans was the most common fungus isolated in cultures. The signs and symptoms most frequently reported among patients with VVC were vaginal discharge and dyspareunia. Regarding antifungals, all isolates showed in vitro susceptibility for most of the drugs tested.
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